Drug improves mobility for some MS patients

The experimental drug fampridine (4-aminopyridine) improves walking ability in some individuals with multiple sclerosis (MS). That is the conclusion of a multi-center Phase 3 clinical trial, the results of which were published today in the journal The Lancet.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news154938328.html">Drug improves mobility for some MS patients</a></p> <p>The experimental drug fampridine (4-aminopyridine) improves walking ability in some individuals with multiple sclerosis (MS). That is the conclusion of a multi-center Phase 3 clinical trial, the results of which were published today in the journal The <I>Lancet</I>.</p>